利托君用于先兆早产合并前置胎盘的临床观察

Clinical Observation of Ritonjun in the Treatment of Threatened Premature Labor With Placenta Previa

目的研究分析先兆早产合并前置胎盘患者接受利托君治疗后的出血情况和新生儿结局。方法选取我院收治的先兆早产合并前置胎盘患者68例作为研究对象,将患者分成对照组和研究组。对照组采用硫酸镁治疗,研究组采用盐酸利托君治疗,每组均有34例患者。对两组的出血情况和新生儿结局进行对比分析。结果研究组保胎成功率为94.12%,对照组胞胎成功率为76.47%,两组保胎成功率对比,差异具有统计学意义(P<0.05);研究组不良反应发生率为11.76%,对照组不良反应率为26.47%。两组不良反应发生率对比,差异不具有统计学意义(P>0.05)。结论先找早产合并前置胎盘患者接受利托君治疗的效果突出,保胎率高,对新生儿结局具有改善作用。

Objective To study the analysis of threatened preterm placenta previa patients receiving ritodrine after treatment of hemorrhage and neonatal outcomes. Methods 68 cases of threatened premature labor with placenta previa were selected as the research objects. The patients were divided into the control group and the research group. The control group was treated with magnesium sulfate, and the study group was treated with hydrochloric acid. There were 34 patients in each group. The bleeding and neonatal outcomes were compared between the two groups. Results The success rate of fetal protection in the study group was 94.12%, while that in the control group was 76.47%. The difference between the two groups wasstatistically significant（P〈0.05）. The adverse reaction rate in the study group was 11.76%, and the adverse reaction rate in the control group was26.47%. There was no significant difference in the incidence of adverse reactions between the two groups（P〈0.05）. Conclusion Early treatment of preterm placenta with placenta previa is effective, and the rate of fetal protection is high.